Related Experiment Video

Updated: Aug 23, 2026

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

[Mumps in Poland in 2002]

Magdalena Rosińska1

  • 1Zakład Epidemiologii Państwowego Zakładu Higieny ul. Chocimska 24, 00-791 Warszawa.

Przeglad Epidemiologiczny
|June 29, 2004
PubMed

Insights

Poland reported a mumps incidence peak in 2002, with over 39,000 cases. Growing vaccine coverage, even without a national program, is credited for a lower peak than in previous years.

Area of Science:

  • Epidemiology
  • Public Health
  • Immunization

Context:

  • Mumps incidence in Poland shows cyclical patterns, with a notable increase observed in 2002.
  • The 2002 mumps outbreak in Poland reported 39,978 cases, a significant rise from 2001.
  • Cyclical mumps incidence in Poland typically occurs every 3-4 years.

Purpose:

  • To analyze the mumps epidemic in Poland in 2002.
  • To assess the impact of increasing vaccine coverage on mumps incidence.
  • To identify the most affected age groups and hospitalization rates.

Summary:

  • The incidence of mumps in Poland in 2002 was 104.6 per 100,000, with children aged 5-9 years being the most affected group.
  • Despite the absence of a national immunization program, mumps vaccine coverage in 3-year-olds reached 35.5% in 2002.
  • Hospitalization rates were approximately 3.5% (1400 cases), with no reported deaths.

Impact:

  • Growing vaccine coverage, even on a voluntary basis, appears to be mitigating the severity of mumps outbreaks.
  • The findings highlight the importance of vaccination in controlling infectious diseases, even when not part of a mandatory national program.
  • The data informs public health strategies for mumps prevention and control in Poland, especially with mandatory immunization for 2-year-olds starting in 2004.

More Related Videos

Merkel Cell Polyomavirus Infection and Detection13:45

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

Murine Model of Epicutaneously-Induced Immunomodulation09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.